Skip to main content

Table 5 Mean changes in Haemoglobin [Hb] after treatment with CPD and AL compared to the Hb changes in the SP treatment group on days 7, 14 and 28.

From: Measurement of adherence, drug concentrations and the effectiveness of artemether-lumefantrine, chlorproguanil-dapsone or sulphadoxine-pyrimethamine in the treatment of uncomplicated malaria in Malawi

 

Treatment Group

Mean Hb

(g/dl)

Contrast with SP group

   

Mean Difference

95% confidence interval

P-value

CPD

Day Number

Day-7

10.42

-0.32

-0.57, -0.08

0.01

 

Day-14

10.83

-0.03

-0.47, 0.41

0.9

 

Day-28

11.29

0.12

-0.18, 0.42

0.45

AL

Day Number

Day-7

11.05

0.32

0.04, 0.60

0.03

 

Day-14

11.31

0.44

-0.06, 0.94

0.09

 

Day-28

11.81

0.64

0.30, 0.98

< 0.001